Biosimilar Market, Global Outlook and Forecast 2022-2028

February 2022 | 60 pages | ID: B9DA43DAC808EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Biosimilar in Global, including the following market information:

Global Biosimilar Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Biosimilar market was valued at 8650.9 million in 2021 and is projected to reach US$ 22110 million by 2028, at a CAGR of 14.3% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Tablet Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Biosimilar include AET BioTech, Amgen, Boehringer Ingelheim, Coherus Biosciences, Fujifilm Kyowa Kirin Biologics, LG Life Sciences/Mochida Pharmaceutical, Momenta Pharmaceuticals, Oncobiologics and Pfizer, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Biosimilar companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Biosimilar Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Biosimilar Market Segment Percentages, by Type, 2021 (%)

• Tablet
• Oral Solution

Global Biosimilar Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Biosimilar Market Segment Percentages, by Application, 2021 (%)

• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy

Global Biosimilar Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Biosimilar Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Biosimilar revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Biosimilar revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• AET BioTech
• Amgen
• Boehringer Ingelheim
• Coherus Biosciences
• Fujifilm Kyowa Kirin Biologics
• LG Life Sciences/Mochida Pharmaceutical
• Momenta Pharmaceuticals
• Oncobiologics
• Pfizer
• Samsung Bioepsis
• Sandoz
• Zydus Cadila

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Biosimilar Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Biosimilar Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL BIOSIMILAR OVERALL MARKET SIZE

2.1 Global Biosimilar Market Size: 2021 VS 2028
2.2 Global Biosimilar Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Biosimilar Players in Global Market
3.2 Top Global Biosimilar Companies Ranked by Revenue
3.3 Global Biosimilar Revenue by Companies
3.4 Top 3 and Top 5 Biosimilar Companies in Global Market, by Revenue in 2021
3.5 Global Companies Biosimilar Product Type
3.6 Tier 1, Tier 2 and Tier 3 Biosimilar Players in Global Market
  3.6.1 List of Global Tier 1 Biosimilar Companies
  3.6.2 List of Global Tier 2 and Tier 3 Biosimilar Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Biosimilar Market Size Markets, 2021 & 2028
  4.1.2 Tablet
  4.1.3 Oral Solution
4.2 By Type - Global Biosimilar Revenue & Forecasts
  4.2.1 By Type - Global Biosimilar Revenue, 2017-2022
  4.2.2 By Type - Global Biosimilar Revenue, 2023-2028
  4.2.3 By Type - Global Biosimilar Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Biosimilar Market Size, 2021 & 2028
  5.1.2 Hospital Pharmacy
  5.1.3 Retail Pharmacy
  5.1.4 Online Pharmacy
5.2 By Application - Global Biosimilar Revenue & Forecasts
  5.2.1 By Application - Global Biosimilar Revenue, 2017-2022
  5.2.2 By Application - Global Biosimilar Revenue, 2023-2028
  5.2.3 By Application - Global Biosimilar Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Biosimilar Market Size, 2021 & 2028
6.2 By Region - Global Biosimilar Revenue & Forecasts
  6.2.1 By Region - Global Biosimilar Revenue, 2017-2022
  6.2.2 By Region - Global Biosimilar Revenue, 2023-2028
  6.2.3 By Region - Global Biosimilar Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Biosimilar Revenue, 2017-2028
  6.3.2 US Biosimilar Market Size, 2017-2028
  6.3.3 Canada Biosimilar Market Size, 2017-2028
  6.3.4 Mexico Biosimilar Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Biosimilar Revenue, 2017-2028
  6.4.2 Germany Biosimilar Market Size, 2017-2028
  6.4.3 France Biosimilar Market Size, 2017-2028
  6.4.4 U.K. Biosimilar Market Size, 2017-2028
  6.4.5 Italy Biosimilar Market Size, 2017-2028
  6.4.6 Russia Biosimilar Market Size, 2017-2028
  6.4.7 Nordic Countries Biosimilar Market Size, 2017-2028
  6.4.8 Benelux Biosimilar Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Biosimilar Revenue, 2017-2028
  6.5.2 China Biosimilar Market Size, 2017-2028
  6.5.3 Japan Biosimilar Market Size, 2017-2028
  6.5.4 South Korea Biosimilar Market Size, 2017-2028
  6.5.5 Southeast Asia Biosimilar Market Size, 2017-2028
  6.5.6 India Biosimilar Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Biosimilar Revenue, 2017-2028
  6.6.2 Brazil Biosimilar Market Size, 2017-2028
  6.6.3 Argentina Biosimilar Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Biosimilar Revenue, 2017-2028
  6.7.2 Turkey Biosimilar Market Size, 2017-2028
  6.7.3 Israel Biosimilar Market Size, 2017-2028
  6.7.4 Saudi Arabia Biosimilar Market Size, 2017-2028
  6.7.5 UAE Biosimilar Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 AET BioTech
  7.1.1 AET BioTech Corporate Summary
  7.1.2 AET BioTech Business Overview
  7.1.3 AET BioTech Biosimilar Major Product Offerings
  7.1.4 AET BioTech Biosimilar Revenue in Global Market (2017-2022)
  7.1.5 AET BioTech Key News
7.2 Amgen
  7.2.1 Amgen Corporate Summary
  7.2.2 Amgen Business Overview
  7.2.3 Amgen Biosimilar Major Product Offerings
  7.2.4 Amgen Biosimilar Revenue in Global Market (2017-2022)
  7.2.5 Amgen Key News
7.3 Boehringer Ingelheim
  7.3.1 Boehringer Ingelheim Corporate Summary
  7.3.2 Boehringer Ingelheim Business Overview
  7.3.3 Boehringer Ingelheim Biosimilar Major Product Offerings
  7.3.4 Boehringer Ingelheim Biosimilar Revenue in Global Market (2017-2022)
  7.3.5 Boehringer Ingelheim Key News
7.4 Coherus Biosciences
  7.4.1 Coherus Biosciences Corporate Summary
  7.4.2 Coherus Biosciences Business Overview
  7.4.3 Coherus Biosciences Biosimilar Major Product Offerings
  7.4.4 Coherus Biosciences Biosimilar Revenue in Global Market (2017-2022)
  7.4.5 Coherus Biosciences Key News
7.5 Fujifilm Kyowa Kirin Biologics
  7.5.1 Fujifilm Kyowa Kirin Biologics Corporate Summary
  7.5.2 Fujifilm Kyowa Kirin Biologics Business Overview
  7.5.3 Fujifilm Kyowa Kirin Biologics Biosimilar Major Product Offerings
  7.5.4 Fujifilm Kyowa Kirin Biologics Biosimilar Revenue in Global Market (2017-2022)
  7.5.5 Fujifilm Kyowa Kirin Biologics Key News
7.6 LG Life Sciences/Mochida Pharmaceutical
  7.6.1 LG Life Sciences/Mochida Pharmaceutical Corporate Summary
  7.6.2 LG Life Sciences/Mochida Pharmaceutical Business Overview
  7.6.3 LG Life Sciences/Mochida Pharmaceutical Biosimilar Major Product Offerings
  7.6.4 LG Life Sciences/Mochida Pharmaceutical Biosimilar Revenue in Global Market (2017-2022)
  7.6.5 LG Life Sciences/Mochida Pharmaceutical Key News
7.7 Momenta Pharmaceuticals
  7.7.1 Momenta Pharmaceuticals Corporate Summary
  7.7.2 Momenta Pharmaceuticals Business Overview
  7.7.3 Momenta Pharmaceuticals Biosimilar Major Product Offerings
  7.7.4 Momenta Pharmaceuticals Biosimilar Revenue in Global Market (2017-2022)
  7.7.5 Momenta Pharmaceuticals Key News
7.8 Oncobiologics
  7.8.1 Oncobiologics Corporate Summary
  7.8.2 Oncobiologics Business Overview
  7.8.3 Oncobiologics Biosimilar Major Product Offerings
  7.8.4 Oncobiologics Biosimilar Revenue in Global Market (2017-2022)
  7.8.5 Oncobiologics Key News
7.9 Pfizer
  7.9.1 Pfizer Corporate Summary
  7.9.2 Pfizer Business Overview
  7.9.3 Pfizer Biosimilar Major Product Offerings
  7.9.4 Pfizer Biosimilar Revenue in Global Market (2017-2022)
  7.9.5 Pfizer Key News
7.10 Samsung Bioepsis
  7.10.1 Samsung Bioepsis Corporate Summary
  7.10.2 Samsung Bioepsis Business Overview
  7.10.3 Samsung Bioepsis Biosimilar Major Product Offerings
  7.10.4 Samsung Bioepsis Biosimilar Revenue in Global Market (2017-2022)
  7.10.5 Samsung Bioepsis Key News
7.11 Sandoz
  7.11.1 Sandoz Corporate Summary
  7.11.2 Sandoz Business Overview
  7.11.3 Sandoz Biosimilar Major Product Offerings
  7.11.4 Sandoz Biosimilar Revenue in Global Market (2017-2022)
  7.11.5 Sandoz Key News
7.12 Zydus Cadila
  7.12.1 Zydus Cadila Corporate Summary
  7.12.2 Zydus Cadila Business Overview
  7.12.3 Zydus Cadila Biosimilar Major Product Offerings
  7.12.4 Zydus Cadila Biosimilar Revenue in Global Market (2017-2022)
  7.12.5 Zydus Cadila Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Biosimilar Market Opportunities & Trends in Global Market
Table 2. Biosimilar Market Drivers in Global Market
Table 3. Biosimilar Market Restraints in Global Market
Table 4. Key Players of Biosimilar in Global Market
Table 5. Top Biosimilar Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Biosimilar Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Biosimilar Revenue Share by Companies, 2017-2022
Table 8. Global Companies Biosimilar Product Type
Table 9. List of Global Tier 1 Biosimilar Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Biosimilar Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Biosimilar Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Biosimilar Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Biosimilar Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Biosimilar Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Biosimilar Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Biosimilar Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Biosimilar Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Biosimilar Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Biosimilar Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Biosimilar Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Biosimilar Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Biosimilar Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Biosimilar Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Biosimilar Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Biosimilar Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Biosimilar Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Biosimilar Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Biosimilar Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Biosimilar Revenue, (US$, Mn), 2023-2028
Table 30. AET BioTech Corporate Summary
Table 31. AET BioTech Biosimilar Product Offerings
Table 32. AET BioTech Biosimilar Revenue (US$, Mn), (2017-2022)
Table 33. Amgen Corporate Summary
Table 34. Amgen Biosimilar Product Offerings
Table 35. Amgen Biosimilar Revenue (US$, Mn), (2017-2022)
Table 36. Boehringer Ingelheim Corporate Summary
Table 37. Boehringer Ingelheim Biosimilar Product Offerings
Table 38. Boehringer Ingelheim Biosimilar Revenue (US$, Mn), (2017-2022)
Table 39. Coherus Biosciences Corporate Summary
Table 40. Coherus Biosciences Biosimilar Product Offerings
Table 41. Coherus Biosciences Biosimilar Revenue (US$, Mn), (2017-2022)
Table 42. Fujifilm Kyowa Kirin Biologics Corporate Summary
Table 43. Fujifilm Kyowa Kirin Biologics Biosimilar Product Offerings
Table 44. Fujifilm Kyowa Kirin Biologics Biosimilar Revenue (US$, Mn), (2017-2022)
Table 45. LG Life Sciences/Mochida Pharmaceutical Corporate Summary
Table 46. LG Life Sciences/Mochida Pharmaceutical Biosimilar Product Offerings
Table 47. LG Life Sciences/Mochida Pharmaceutical Biosimilar Revenue (US$, Mn), (2017-2022)
Table 48. Momenta Pharmaceuticals Corporate Summary
Table 49. Momenta Pharmaceuticals Biosimilar Product Offerings
Table 50. Momenta Pharmaceuticals Biosimilar Revenue (US$, Mn), (2017-2022)
Table 51. Oncobiologics Corporate Summary
Table 52. Oncobiologics Biosimilar Product Offerings
Table 53. Oncobiologics Biosimilar Revenue (US$, Mn), (2017-2022)
Table 54. Pfizer Corporate Summary
Table 55. Pfizer Biosimilar Product Offerings
Table 56. Pfizer Biosimilar Revenue (US$, Mn), (2017-2022)
Table 57. Samsung Bioepsis Corporate Summary
Table 58. Samsung Bioepsis Biosimilar Product Offerings
Table 59. Samsung Bioepsis Biosimilar Revenue (US$, Mn), (2017-2022)
Table 60. Sandoz Corporate Summary
Table 61. Sandoz Biosimilar Product Offerings
Table 62. Sandoz Biosimilar Revenue (US$, Mn), (2017-2022)
Table 63. Zydus Cadila Corporate Summary
Table 64. Zydus Cadila Biosimilar Product Offerings
Table 65. Zydus Cadila Biosimilar Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Biosimilar Segment by Type in 2021
Figure 2. Biosimilar Segment by Application in 2021
Figure 3. Global Biosimilar Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Biosimilar Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Biosimilar Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Biosimilar Revenue in 2021
Figure 8. By Type - Global Biosimilar Revenue Market Share, 2017-2028
Figure 9. By Application - Global Biosimilar Revenue Market Share, 2017-2028
Figure 10. By Region - Global Biosimilar Revenue Market Share, 2017-2028
Figure 11. By Country - North America Biosimilar Revenue Market Share, 2017-2028
Figure 12. US Biosimilar Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Biosimilar Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Biosimilar Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Biosimilar Revenue Market Share, 2017-2028
Figure 16. Germany Biosimilar Revenue, (US$, Mn), 2017-2028
Figure 17. France Biosimilar Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Biosimilar Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Biosimilar Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Biosimilar Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Biosimilar Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Biosimilar Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Biosimilar Revenue Market Share, 2017-2028
Figure 24. China Biosimilar Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Biosimilar Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Biosimilar Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Biosimilar Revenue, (US$, Mn), 2017-2028
Figure 28. India Biosimilar Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Biosimilar Revenue Market Share, 2017-2028
Figure 30. Brazil Biosimilar Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Biosimilar Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Biosimilar Revenue Market Share, 2017-2028
Figure 33. Turkey Biosimilar Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Biosimilar Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Biosimilar Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Biosimilar Revenue, (US$, Mn), 2017-2028
Figure 37. AET BioTech Biosimilar Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Amgen Biosimilar Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Boehringer Ingelheim Biosimilar Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Coherus Biosciences Biosimilar Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Fujifilm Kyowa Kirin Biologics Biosimilar Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. LG Life Sciences/Mochida Pharmaceutical Biosimilar Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Momenta Pharmaceuticals Biosimilar Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Oncobiologics Biosimilar Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Pfizer Biosimilar Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Samsung Bioepsis Biosimilar Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Sandoz Biosimilar Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Zydus Cadila Biosimilar Revenue Year Over Year Growth (US$, Mn) & (2017-2022)